Provided is a compound having a monoamine reuptake inhibitory activity, which is represented by the formula (I)
wherein ring A is an optionally substituted 6-membered aromatic ring, ring B is
the substituents on ring A are optionally bonded to form, together with ring A, an optionally substituted 9- or 10-membered aromatic fused ring, and other symbols are as defined in the specification, or a salt thereof.
Provided is a compound having a monoamine reuptake inhibitory activity, which is represented by the formula (I) wherein ring A is an optionally substituted 6-membered aromatic ring, ring B is the substituents on ring A are optionally bonded to form, together with ring A, an optionally substituted 9- or 10-membered aromatic fused ring, and other symbols are as defined in the specification, or a salt thereof.
[EN] 1,4-OXAZEPANE DERIVATIVES<br/>[FR] DÉRIVÉS DE 1,4-OXAZÉPANE
申请人:TAKEDA PHARMACEUTICAL
公开号:WO2012046882A1
公开(公告)日:2012-04-12
Provided is a compound having a monoamine reuptake inhibitory activity, which is represented by the formula (I) wherein ring A is an optionally substituted 6-membered aromatic ring, ring B is the substituents on ring A are optionally bonded to form, together with ring A, an optionally substituted 9- or 10-membered aromatic fused ring, and other symbols are as defined in the specification, or a salt thereof.
Heterocyclic compounds
申请人:Ishichi Yuji
公开号:US08722662B2
公开(公告)日:2014-05-13
Provided is a compound having a monoamine reuptake inhibitory activity, which is represented by the formula (I)
wherein ring A is an optionally substituted 6-membered aromatic ring, ring B is
the substituents on ring A are optionally bonded to form, together with ring A, an optionally substituted 9- or 10-membered aromatic fused ring, and other symbols are as defined in the specification, or a salt thereof.